Edesa Biotech, Inc. (Nasdaq: EDSA) is a clinical-stage biopharmaceutical company developing innovative ways to treat inflammatory and immune-related diseases. Our most advanced drug candidate is EB05 (paridiprubart), a monoclonal antibody developed for acute and chronic disease indications that involve dysregulated innate immune responses. Edesa is currently evaluating EB05 in a Phase 3 study as a potential treatment for Acute Respiratory Distress Syndrome (ARDS), a life-threatening form of respiratory failure. In addition, Edesa is developing an sPLA2 inhibitor, EB01, as a topical treatment for chronic Allergic Contact Dermatitis (ACD), a common occupational skin condition. The company has also received regulatory approval to conduct a Phase 2 trial its EB06 monoclonal antibody as a treatment for vitiligo, a life-altering autoimmune disease that causes skin to lose its color in patches. We also are planning a future Phase 2 study of paridiprubart for systemic sclerosis (scleroderma), an autoimmune rheumatic disorder that causes fibrosis (scarring/hardening) of skin and internal organs.
View Top Employees from Edesa Biotech, Inc.Website | http://www.edesabiotech.com/ |
Ticker | EDSA |
Revenue | $5.4 million |
Employees | 21 (21 on RocketReach) |
Founded | 2015 |
Address | 100 Spy Court, Markham, Ontario L3R 5H6, CA |
Phone | (289) 800-9600 |
Industry | Biotechnology Research, Pharmaceuticals, Healthcare |
Competitors | AZTherapies, KBP Biosciences, NeuroRx Pharma, Retrotope, Inc., Soligenix, Inc. |
SIC | SIC Code 28 Companies, SIC Code 283 Companies |
NAICS | NAICS Code 32541 Companies, NAICS Code 3254 Companies, NAICS Code 541 Companies, NAICS Code 32 Companies, NAICS Code 325 Companies, NAICS Code 54 Companies, NAICS Code 5417 Companies |
Looking for a particular Edesa Biotech, Inc. employee's phone or email?
The Edesa Biotech, Inc. annual revenue was $5.4 million in 2024.
Kathi Niffenegger is the CFO of Edesa Biotech, Inc..
21 people are employed at Edesa Biotech, Inc..
Edesa Biotech, Inc. is based in Markham, Ontario.
The NAICS codes for Edesa Biotech, Inc. are [32541, 3254, 541, 32, 325, 54, 5417].
The SIC codes for Edesa Biotech, Inc. are [28, 283].